|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2004-5-10
|
|
pubmed:abstractText |
Inflammation is one of the main pathogeneses of neointimal hyperplasia after coronary intervention. Thalidomide, because of its potent antiinflammatory and immunomodulatory properties, is being re-evaluated in several clinical fields. Therefore, we examined whether thalidomide therapy affects neointimal formation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1524-4636
|
|
pubmed:author |
pubmed-author:ChaeIn-HoIH,
pubmed-author:ChoiDong-JooDJ,
pubmed-author:JeonSoo-InSI,
pubmed-author:KimDae-HeeDH,
pubmed-author:KimHyo-SooHS,
pubmed-author:KooBon-KwonBK,
pubmed-author:LeeMyoung-MookMM,
pubmed-author:OhByung-HeeBH,
pubmed-author:ParkKyung-WooKW,
pubmed-author:ParkSeung-JungSJ,
pubmed-author:ParkYoung-BaeYB,
pubmed-author:YangHan-MoHM,
pubmed-author:YounSeock-WonSW
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
885-91
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:14988093-Animals,
pubmed-meshheading:14988093-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:14988093-Balloon Dilation,
pubmed-meshheading:14988093-Carotid Arteries,
pubmed-meshheading:14988093-Carotid Stenosis,
pubmed-meshheading:14988093-Drug Evaluation, Preclinical,
pubmed-meshheading:14988093-Fibroblast Growth Factor 2,
pubmed-meshheading:14988093-Hyperplasia,
pubmed-meshheading:14988093-Inflammation,
pubmed-meshheading:14988093-Macrophages,
pubmed-meshheading:14988093-Male,
pubmed-meshheading:14988093-Rats,
pubmed-meshheading:14988093-Rats, Sprague-Dawley,
pubmed-meshheading:14988093-Thalidomide,
pubmed-meshheading:14988093-Tumor Necrosis Factor-alpha,
pubmed-meshheading:14988093-Tunica Intima,
pubmed-meshheading:14988093-Vasculitis
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Thalidomide as a potent inhibitor of neointimal hyperplasia after balloon injury in rat carotid artery.
|
|
pubmed:affiliation |
Cardiovascular Laboratory, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
